Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

NCT00001131 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Aldesleukin
DRUG: HAART

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)